← Browse by Condition
Medical Condition
solid tumors
Total Trials
22
Recruiting Now
22
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for solid tumors sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — solid tumors Clinical Trials
How many clinical trials are currently recruiting for solid tumors?
ClinicalMetric currently tracks 22 actively recruiting clinical trials for solid tumors, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 22. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for solid tumors?
solid tumors research spans Phase 1 (18 trials), Phase 2 (8 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a solid tumors clinical trial?
Eligibility criteria for solid tumors trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 18
Phase 2 8
Phase 3 1
Top Sponsors
2 trials
2 trials
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05471856 Phase 1
Recruiting
Enrollment
66 pts
Location
United States, Japan...
Sponsor
Boehringer Ingelheim
NCT06816992 Phase 1
Recruiting
Enrollment
76 pts
Location
United States, Austr...
Sponsor
ORIC Pharmaceuticals
NCT07016997 Phase 1
Recruiting
Enrollment
70 pts
Location
Japan
Sponsor
Chiome Bioscience Inc.
NCT06636435 Phase 1
Recruiting
Enrollment
66 pts
Location
Japan
Sponsor
Chiome Bioscience Inc.
NCT07105215 Phase 1, Phase 2
Recruiting
Enrollment
312 pts
Location
China
Sponsor
RemeGen Co., Ltd.
NCT06826313 Phase 1
Recruiting
Enrollment
12 pts
Location
China
Sponsor
Guangzhou Virotech Pharmaceuti...
NCT06973863 Phase 1
Recruiting
Enrollment
40 pts
Location
Australia, Taiwan
Sponsor
PharmaEngine
NCT06644755 Phase 1
Recruiting
Enrollment
150 pts
Location
United States, Belgi...
Sponsor
Daiichi Sankyo
NCT05101070 Phase 1, Phase 2
Recruiting
Enrollment
282 pts
Location
United States, Japan
Sponsor
Shionogi
NCT03486873 Phase 3
Recruiting
Enrollment
3,500 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC
NCT07181681 Phase 1
Recruiting
Enrollment
63 pts
Location
United States, Austr...
Sponsor
BeOne Medicines
NCT05490472 Phase 1, Phase 2
Recruiting
Enrollment
102 pts
Location
United States, China
Sponsor
Jacobio Pharmaceuticals Co., L...
NCT07249060
Recruiting
Enrollment
300 pts
Location
Spain
Sponsor
Hospital Universitario Araba
NCT06710379 Phase 1
Recruiting
Enrollment
68 pts
Location
United States
Sponsor
Adcentrx Therapeutics
NCT04685226 Phase 1, Phase 2
Recruiting
Enrollment
310 pts
Location
China
Sponsor
Beijing InnoCare Pharma Tech C...
NCT07159126 Phase 1
Recruiting
Enrollment
70 pts
Location
United States, Franc...
Sponsor
Daiichi Sankyo
NCT07492680 Phase 2
Recruiting
Enrollment
254 pts
Location
United States, Belgi...
Sponsor
Bristol-Myers Squibb
NCT07351903 Phase 1
Recruiting
Enrollment
15 pts
Location
China
Sponsor
Tianjin Medical University Can...
NCT07415031 Phase 2
Recruiting
Enrollment
170 pts
Location
United States, Austr...
Sponsor
Mirati Therapeutics Inc.
NCT07265622 Phase 1, Phase 2
Recruiting
Enrollment
200 pts
Location
China
Sponsor
Mabwell (Shanghai) Bioscience ...
NCT07002203 Phase 1, Phase 2
Recruiting
Enrollment
10 pts
Location
Thailand
Sponsor
Seqker Biosciences, Inc.
NCT07030959 Phase 1
Recruiting
Enrollment
130 pts
Location
United States, Japan
Sponsor
Chugai Pharmaceutical
Related Conditions
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology